Clinical Trial Update: Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen

View source ↗

Summary

A completed clinical trial update examining postoperative T and B cell dysfunction in cancer surgery patients, using COVID-19 as a model antigen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Abdominal Cancer | Status: COMPLETED